Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F67K4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,630
Award facts
- Contract value 100% obligated
- $18,630.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,630.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML Pen (0.4ML) on February 4, 2026, with an ultimate completion date of February 5, 2026. This non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at up to $999,999,999.00 through December 2026. The place of performance is Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical procurement.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that supplies critical medical commodities to military healthcare systems and other federal agencies. KESIMPTA is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the company's extensive portfolio of medications across multiple therapeutic domains. The company's IDC vehicle enables flexible and comprehensive pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with demonstrated capability to deliver medications ranging from generic drugs to specialty brand-name products across global military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F67K4?
SPE2DR26F67K4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F67K4 worth?
The government has obligated $18,630 on SPE2DR26F67K4.
Is contract SPE2DR26F67K4 an order under another contract?
Yes. SPE2DR26F67K4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67K4 competed?
The extent of competition for SPE2DR26F67K4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award